Upper GI 2017

Response to chemotherapy / CRT

Predict outcome for OG patients • responders to neoadjuvant therapy benefit most post surgery • non-responders to neoadjuvant therapy have a poorer prognosis post op than those who have primary surgery alone* β • Individualise patient care

*Ancona E, Ruol A et al. 2001. Cancer; 91:2165-2174 β Law S, Fok M et al 1997. J Thorac Cardiovasc Surg; 14: 210-217